Photobiomodulation modulates inflammation and oral microbiome: a pilot study

References

• Alves, A.C., et al., 2013. Effect of low-level laser therapy on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation. Arthritis research & therapy, 15 (5), R116.
   PubMed Web of Science ®Google Scholar
• Bjordal, J.M., et al., 2011. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Supportive care in cancer: official journal of the multinational association of supportive care in cancer, 19 (8), 1069–1077.
   PubMed Web of Science ®Google Scholar
• Caporaso, J.G., et al., 2010. QIIME allows analysis of high-throughput community sequencing data. Nature methods, 7 (5), 335–336.
   PubMed Web of Science ®Google Scholar
• Chen, T., et al., 2010. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database: the journal of biological databases and curation, 2010, baq013.
   PubMed Web of Science ®Google Scholar
• Chermetz, M., et al., 2014. Class IV laser therapy as treatment for chemotherapy-induced oral mucositis in onco-haematological paediatric patients: a prospective study. International journal of paediatric dentistry, 24 (6), 441–449.
   PubMed Web of Science ®Google Scholar
• de Koning, B.A., et al., 2006. Contributions of mucosal immune cells to methotrexate-induced mucositis. International immunology, 18 (6), 941–949.
   PubMed Web of Science ®Google Scholar
• dos Santos, S.A., et al., 2014. Comparative analysis of two low-level laser doses on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation. Lasers in medical science., 29 (3), 1051–1058.
   PubMed Web of Science ®Google Scholar
• Elad, S., et al., 2020. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 126 (19), 4423–4431.
   PubMed Web of Science ®Google Scholar
• Edgar, R.C., 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (oxford, England)), 26 (19), 2460–2461.
   PubMed Web of Science ®Google Scholar
• Elting, L.S., et al., 2007. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. International journal of radiation oncology biology physics., 68 (4), 1110–1120.
   PubMed Web of Science ®Google Scholar
• Gobbo, M., et al., 2014. Evaluation of nutritional status in head and neck radio-treated patients affected by oral mucositis: efficacy of class IV laser therapy. Supportive care in cancer: official journal of the multinational association of supportive care in cancer, 22 (7), 1851–1856.
   PubMed Web of Science ®Google Scholar
• Hoogstraten, B., et al., 1979., WHO handbook for reporting results of cancer treatment, WHO offset publication (Vol. 20, no. 48). Geneva: WHO.
   Google Scholar
• Hoyt, R., et al., 2010. Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX. Bone marrow transplantation, 45 (9), 1457–1462.
   PubMed Web of Science ®Google Scholar
• Kanuga, S., 2013. Cryotherapy and keratinocyte growth factor may be beneficial in preventing oral mucositis in patients with cancer, and sucralfate is effective in reducing its severity. Journal of the American dental association, 144 (8), 928–929.
   PubMedGoogle Scholar
• Lalla, R.V., et al., 2012. A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Supportive care in cancer: official journal of the multinational association of supportive care in cancer, 20 (8), 1797–1804.
   PubMed Web of Science ®Google Scholar
• Logan, R.M., et al., 2007a. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer treatment reviews, 33 (5), 448–460.
   PubMed Web of Science ®Google Scholar
• Logan, R.M., et al., 2007b. Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral oncology, 43 (4), 395–401.
   PubMed Web of Science ®Google Scholar
• Logan, R.M., et al., 2008. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer biology & therapy, 7 (7), 1139–1145.
   PubMed Web of Science ®Google Scholar
• Logan, R.M., et al., 2009. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer chemotherapy and pharmacology, 63 (2), 239–251.
   PubMed Web of Science ®Google Scholar
• Migliorati, C., et al., 2013. Mucositis study group of the multinational association of supportive care in cancer/international society of oral oncology 2013. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Supportive care in cancer: official journal of the multinational association of supportive care in cancer, 21 (1), 333–341.,
   PubMedGoogle Scholar
• Napenas, J.J., et al., 2007. Relationship between mucositis and changes in oral microflora during cancer chemotherapy. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 103 (1), 48–59.
   PubMed Web of Science ®Google Scholar
• Oton-Leite, A.F., et al., 2015. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers in surgery and medicine, 47 (4), 296–305.
   PubMed Web of Science ®Google Scholar
• Ottaviani, G., et al., 2013. Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. The American journal of pathology, 183 (6), 1747–1757.
   PubMed Web of Science ®Google Scholar
• Palmer, R.J., Jr., 2014. Composition and development of oral bacterial communities. Periodontology 2000, 64 (1), 20–39.
   PubMed Web of Science ®Google Scholar
• Peterson, D.E., et al., 2015. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann oncol, 26 (5), 139–151.
   Google Scholar
• Pires, D., et al., 2011. Low-level laser therapy (LLLT; 780 nm) acts differently on mRNA expression of anti- and pro-inflammatory mediators in an experimental model of collagenase-induced tendinitis in rat. Lasers in medical science, 26 (1), 85–94.
   PubMed Web of Science ®Google Scholar
• Rideout, J.R., et al., 2014. Subsampled open-reference clustering creates consistent, comprehensive OTU definitions and scales to billions of sequences. PeerJ., 2, e545.
   PubMed Web of Science ®Google Scholar
• Silva, G.B., et al., 2015. Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Lasers in medical science, 30 (1), 117–126.
   PubMed Web of Science ®Google Scholar
• Sonis, S.T., et al., 2000. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral oncology, 36 (4), 373–381.
   PubMed Web of Science ®Google Scholar
• Sonis, S.T., 2004. A biological approach to mucositis. The journal of supportive oncology, 2 (1), 21–32.
   PubMedGoogle Scholar
• Sonis, S.T., et al., 2004. Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology. 2004. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer, 100 (9 Suppl), 1995–2025.
   PubMed Web of Science ®Google Scholar
• Sonis, S.T., 2007. Pathobiology of oral mucositis: novel insights and opportunities. The journal of supportive oncology, 5 (9 Suppl 4), 3–11.
   PubMedGoogle Scholar
• Sonis, S., et al., 2007. Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral oncology, 43 (3), 289–300.
   PubMed Web of Science ®Google Scholar
• Stringer, A.M., et al., 2009. Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change. Current drug metabolism, 10 (1), 79–83.
   PubMed Web of Science ®Google Scholar
• Stringer, A.M., and Logan, R.M., 2015. The role of oral flora in the development of chemotherapy-induced oral mucositis. Journal of Oral Pathology & Medicine, 44 (2), 81–87.
   PubMed Web of Science ®Google Scholar
• Sundquist, A., et al., 2007. Bacterial flora-typing with targeted, chip-based Pyrosequencing. BMC microbiology, 7 (1), 108.
   PubMedGoogle Scholar
• Wang, Y., Zhou, X., and Xu, X., 2015. Oral microbiota: an overlooked etiology for chemotherapy-induced oral mucositis? Journal of the formosan medical association = Taiwan yi zhi, 114 (4), 297–299.
   PubMed Web of Science ®Google Scholar
• Yeoh, A.S., et al., 2005. Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. International journal of radiation oncology, biology, physics, 63 (5), 1295–1303.
   PubMed Web of Science ®Google Scholar
• Zadik, Y., et al., 2019. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive care in cancer: official journal of the multinational association of supportive care in cancer, 27 (10), 3969–3983., Oct
   PubMed Web of Science ®Google Scholar
• Zanotta, N., et al., 2018. Cytokine profiles of women with vulvodynia: identification of a panel of pro-inflammatory molecular targets. European journal of obstetrics, gynecology, and reproductive biology, 226, 66–70.
   PubMed Web of Science ®Google Scholar
• Zupin, L., et al., 2018. Effect of laser therapy on defensins’ gene expression in TR146 epithelial cell line. Protein and peptide letters, 25 (4), 326–329.
   PubMed Web of Science ®Google Scholar